Return on Investments: An indicator of how profitable a company is relative to its assets invested by shareholders and long-term bond holders. Calculated by dividing a company's operating earnings by its long-term debt and shareholders equity. Calculated as: Income from Continuing Operations / (Total Long-Term Debt + Shareholders Equity)
Benitec Biopharma Limited (BNTC) had Return on Investments of -38.77% for the most recently reported fiscal year, ending 2025-06-30.
| Income Statement Financials | |
-- |
|
$-37.92M |
|
-- |
|
-- |
|
$41.77M |
|
$-41.77M |
|
$3.85M |
|
$-37.92M |
|
$-37.92M |
|
$-37.92M |
|
$-37.92M |
|
$-37.92M |
|
$-37.92M |
|
$-41.77M |
|
$-41.70M |
|
36.21M |
|
36.21M |
|
$-1.05 |
|
$-1.05 |
|
| Balance Sheet Financials | |
$98.52M |
|
$0.13M |
|
$1.07M |
|
$99.59M |
|
$1.80M |
|
$0.49M |
|
$0.49M |
|
$2.30M |
|
$97.30M |
|
$97.30M |
|
$97.30M |
|
26.25M |
|
| Cash Flow Statement Financials | |
$-23.59M |
|
$-0.02M |
|
$70.48M |
|
$50.93M |
|
$97.86M |
|
$46.93M |
|
$17.43M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
54.67 |
|
-- |
|
-- |
|
0.01 |
|
0.01 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-23.61M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-38.97% |
|
-38.97% |
|
-38.07% |
|
|
Return on Investments |
-38.77% |
$3.71 |
|
$-0.65 |
|
$-0.65 |
|